A drug being developed by Biogen and Denali Therapeutics to treat Parkinson's didn't slow down progression of the disease in a recent trial. BIIB122, which is in a Phase 2b trial to treat early-stage ...

Parkinson drug development halted as Biogen and Denali stop BIIB122 after phase 2b trial failed to slow disease progression.

Michael Koob, PhD, and his team from University of Minnesota Medical School have been selected to join the Collaborative ...

Parkinson's disease is often seen as a condition that affects older adults. However, thousands of people worldwide develop symptoms much earlier, sometimes in their 30s or 40s. Known as Early-Onset ...

(WNDU) - Visual hallucinations affect up to 75% of Parkinson’s patients. These visual hallucinations cause them to see things that aren’t really there. Now, there is a medication that targets these ...

Sinemet (carbidopa/levodopa) is a prescription oral tablet that’s used to treat Parkinson’s disease and parkinsonism in adults. This drug can interact with alcohol, other medications, some supplements ...

Cayuga Health neurologists have decades of experience treating Parkinson’s disease, a movement disorder of the nervous system. Parkinson’s symptoms develop over many years. People can have difficulty ...